About Aaron Missere
Aaron Missere is the CEO and founder of financial media company Departures Capital Inc. He is an avid and experienced investor, with a primary focus on the cannabis industry. In addition to being a featured contributor to StockNews.com and ETFDailyNews.com, he is an author for SmarterAnalyst.com. Aaron also currently hosts a weekly show on YouTube that recaps and explains the movement in the stock market, with a heavy emphasis on marijuana stocks.
Recent Articles By Aaron Missere
Will ACB Ever Recover?
Aurora Cannabis (ACB) has been trending downward as of late. The company needs to make a number of changes to become a stock worthy of your attention again.
Why is GrowGeneration Skyrocketing This Week?
GrowGeneration (GRWG), which just released it most recent financial results, has been on a tear. Learn what management has in store for the future.
Why Did Shares of Tilray Fall After Earnings?
Tilray (TLRY) reported earnings on Monday and investors were not pleased. Learn how TLRY performed.
Canopy Surprises with Better Than Expected Earnings
Canopy Growth (CGC) was able to deliver better than expected earnings. Learn more about its most recent quarter.
Cannabis Stock Weekly Recap
The cannabis industry was down for the week due to mixed news. Innovative Industrial Properties (IIPR) posted strong earnings, Aurora Cannabis (ACB) was trending downward, and GW Pharmaceuticals (GWPH) posted modest earnings.
Did IIPR Report Another Stellar Quarter?
Innovative Industrial Properties (IIPR) reported Q2 earnings on Wednesday. Learn how the company performed.
Will Aphria's New Supply Agreement Spark a Rally?
Aphria (APHA) signed an agreement with Israeli leader Canndoc to provide dried bulk flower to Israel's largest drugstore chain.
GW Pharma Paves the Way to More Revenue
The FDA just approved GW Pharmaceuticals (GWPH) Epidiolex Oral Solution to treat seizures associated with Tuberous Sclerosis Complex. This is the third approval for the drug.
Cannabis Stock Weekly Recap
The cannabis sector ended flat for the week. Aurora Cannabis (ACB) came close to trading in single digits and Aphria (APHA) recorded a $99 million loss.